NCT02906761View on ClinicalTrials.gov

Aspirin for Uncontrolled Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

June 17, 2021

Study Completion Date

June 17, 2021

Conditions
Uncontrolled Asthma
Interventions
DRUG

Aspirin

Aspirin 600 mg (2 tablets of 300 mg) twice daily for 6 months

DRUG

Placebo

Placebo (2 tablets) twice daily for 6 months

Trial Locations (9)

21000

Service de Pneumologie - Hôpital François Mitterrand - CHU Dijon, Dijon

31009

Service de pneumologie - Hôpital Larrey, Toulouse

59037

Service de pneumologie - Hôpital Calmette - CHRU Lille, Lille

69004

Service de Pneumologie - La Croix Rousse, Lyon

75018

CIC - Hôpital Bichat, Paris

94270

Service de Pneumologie - Hôpital Bicêtre, Le Kremlin-Bicêtre

Unknown

Service de pneumologie - CHU Besançon, Besançon

Service de pneumologie - Hôpital Charles Nicolle - CHU Rouen, Rouen

Service de pneumologie - Nouvel Hopital Civil - CHU strasbourg, Strasbourg

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02906761 - Aspirin for Uncontrolled Asthma | Biotech Hunter | Biotech Hunter